The largest database of trusted experimental protocols

15 protocols using site direct mutagenesis kit

1

Identifying miR-190b Targets in FOXP2

Check if the same lab product or an alternative is used in the 5 most similar protocols
TargetScan version 7.2 (targetscan.org/vert_72/) analysis was performed to determine the potential targets of miR-190b and a total of 223 genes were identified. Among these genes, FOXP2 was selected for following studies. Wild-type 3′-UTR of FOXP2 was amplified from the human CRC cell genome with the primers (Sense, 5′-GGTACCCTTTACAAACAGTTTTGACAG-3′, and antisense, 5′-AAGCTTTGGTGTGAATGATGACTGG-3′) and cloned into pGL3 luciferase vector (Promega Corporation) and termed pGL3-FOXP2-wt. A site-direct mutagenesis kit (Takara Bio, Inc.) was used mutate the FOXP2 3′-UTR using the primers (Fragment 1, forward 5′-CAGCGATCGCGAACTGACTTGTGAAACCTCAGCG-3′, reverse, 5′-CTCGCAGTTACTTCCAGTCCCTCAAAGCC-3′; and fragment 2, forward 5′-GTCTTTGGGTCATGATCAACGAACCGG-3′ and reverse, 5′-TATGTTTAAACTTTATAAATGGGTCAAAAAGAATTAGA-3′) and this was termed pGL3-FOXP2-mut. Cells were co-transfected with pGL3-FOXP2-mut or pGL3-FOXP2-wt combined with miR-190b inhibitor or NC-inhibitor using Lipofectamine® 2000. Luciferase activity was measured using a Dual-Luciferase reporter system (Promega Corporation) after 48 h of transfection.
+ Open protocol
+ Expand
2

Validating miRNA Targeting of CASC9 and S100A14

Check if the same lab product or an alternative is used in the 5 most similar protocols
Wild-type (wt) sequence of CASC9 or S100A14 contains a binding region for miR-335-3p was inserted into psi-CHECK-2 (Promega. Madison, WI, USA) to generate wt-CASC9 or wt-S100A14. Mutant luciferase vectors (mt-CASC9 or mt-S100A14) were constructed using site-direct mutagenesis kit (Takara) to lose miR-335-3p binding sites. Cells were co-transfected with luciferase vectors and miRNAs using Lipofectamine 2000. 48 hrs later, dual-luciferase activity system (Promega) was utilized to measure relative luciferase activity using Renilla luciferase as internal control.
+ Open protocol
+ Expand
3

Luciferase Reporter Assay for miRNA Targets

Check if the same lab product or an alternative is used in the 5 most similar protocols
pmiR-Report luciferase vector contains wild-type (wt) sequence of PART1 or HMGB2 was named as wt-PART1/HMGB2. Mutant luciferase vectors were constructed using site-direct mutagenesis kit (Takara) and named as mt-PART1/HMGB2. Cells were transfected with luciferase reporter vectors and miRNAs using Lipofectamine 2000. After 48 h transfection, relative luciferase activity was measured using Dual-luciferase reporter assay kit (Promega, Madison, WI, USA).
+ Open protocol
+ Expand
4

Validation of miR-106a Binding to HAND2-AS1 and RBM24

Check if the same lab product or an alternative is used in the 5 most similar protocols
miR-106a-5p ranks top for all the targets for HAND2-AS1, while RBM24 ranks top among targets for miR-106a-4p. Sequence of HAND2-AS1 or RBM24 containing predicted miR-106a-5p binding sequence was inserted into Dual‐luciferase Expression Vector (Promega, Madison, WI, USA) to generate HAND2-AS1 wild‐type (HAND2-AS1‐wt) or RBM24 wild-type (RBM24-wt). The mutant luciferase activity vector was built with/site-direct mutagenesis kit (Takara) and then these vectors were named HAND2-AS1-mt or RBM24-mt. After 48 h transfection, relative luciferase activities were measured using Dual‐luciferase reporter assay system (Promega).
+ Open protocol
+ Expand
5

Validating miR-451a and TRIM66 interaction

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bioinformatic algorithms (http://www.targetscan.org/vert_72/) predicted that TRIM66 was a potential target of miR-451a. The wild-type 3′-UTR of TRIM66 was cloned from genome and inserted into pMIR-REPORT (Promega, Madison, Wisconsin) and named as wt-TRIM66. The mutant type of 3′-UTR of TRIM66 (mt-TRIM66) was built from wt-TRIM66 using site-direct mutagenesis kit (Takara). Cells were cotransfected with wt-TRIM66 or mt-TRIM66 and miR-451a mimic or NC mimic using Lipofectamine 2000. After 48 hours of transfection, relative luciferase activity was analyzed using Dual-luciferase Reporter Assay System (Promega).
+ Open protocol
+ Expand
6

Investigating miR-383-5p Interactions with LINC00096 and RBM3

Check if the same lab product or an alternative is used in the 5 most similar protocols
The LINC00096 cDNA sequence contains the binding site for miR-383-5p was inserted into pmiR-GLO vector to obtain a wild-type LINC00096 (LINC00096-Wt). Mutant LINC00096 (LINC00096-Mut) was constructed using site-direct mutagenesis kit (Takara). To investigate the association between miR-383-5p and RBM3, 3ʹ-UTR of RBM3 contains miR-383-5p binding site was cloned into pmiR-GLO. Cells were transfected with LINC00096-Wt or RBM3-Wt and miR-383-5p mimics using Lipofectamine 2000. After 48h of transfection, luciferase activity was measured with Dual-Luciferase Reporter Assay System (Promega) according to the manufacturer’s protocols.
+ Open protocol
+ Expand
7

miR-1249-3p Regulation of HNRNPK

Check if the same lab product or an alternative is used in the 5 most similar protocols
TargetScan v_7.2 (http://www.targetscan.org/vert_72/) was employed to predict the potential target of miR‐1249‐3p and we found HNRNPK was a possible target. The wild‐type (wt) 3′‐UTR (NM_001318186.1) was amplified from genomic DNA obtained from HCC cells and inserted into pMIR‐REPORT (Promega) to obtain HNRNPK‐wt. Site‐direct mutagenesis kit (Takara) was used to generate mutant HNRNPK luciferase vector version (HNRNPK‐mt). Cells were cotransfected with HNRNPK‐wt or HNRNPK‐mt and miR‐inhibitor or miR‐NC using Lipofectamine 2000. Forty‐eight hours after cotransfection, relative luciferase activity was measured using Dual‐luciferase activity reporter assay system (Promega).
+ Open protocol
+ Expand
8

Constructing NCK1 3'-UTR Reporter Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
According to the results of the bioinformatics prediction, NCK1 was selected as a putative target for miR-374a-5p. The wild-type (wt) 3'-UTR containing the binding site for miR-374a-5p was synthesized by GenScript, cloned into pGL3 vector (Promega Corporation) and named as NCK1-wt. Mutant (mt) 3'-UTR of NCK1 was constructed from NCK1-wt using a site-direct mutagenesis kit (Takara Biotechnology, Co., Ltd.) and named as NCK1-mt.
+ Open protocol
+ Expand
9

Luciferase Assay for lncRNA Targets

Check if the same lab product or an alternative is used in the 5 most similar protocols
The amplified wild-type fragment of USP2-AS1 or KIAA1522 was inserted into the pmirGLO vector (Promega, Madison, WI, USA) for acquiring USP2-AS1 WT or KIAA1522 WT. Site-direct mutagenesis kit (Takara) was utilized to acquire mutant luciferase vectors (USP2-AS1 MUT and KIAA1522 MUT). Relative luciferase activity was assayed by Dual-Luciferase Reporter Assay System (Promega) after 48 hours of cell co-transfection with indicated reporter vectors and miR-520d-3p mimics or NC mimics. The activity of Renilla luciferase was employed as the internal control. Three repeated experiments were undertaken.
+ Open protocol
+ Expand
10

Luciferase Reporter Assay for miRNA Targets

Check if the same lab product or an alternative is used in the 5 most similar protocols
The amplified wild-type FOXP4-AS1 or CBX4 sequences were inserted into pmirGLO vector (GeneChem, Shanghai, China) to generate FOXP4-AS1-wt or CBX4-wt. Site-direct mutagenesis kit (Takara) was used to generate mutant luciferase vectors and termed as FOXP4-AS1-mt or CBX4-mt. Cells were co-transfected with luciferase constructs and miR-136-5p mimic or NC-mimic using Lipofectamine 2000. Dual-Luciferase Reporter Assay System (Promega, Madison, WI, USA) was used to measure relative luciferase activity after 48 h of transfection using Renilla luciferase as internal control. Experiments were repeated in triplicates.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!